AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Proposed listing date: 1 AUGUST 2017 11:00AM AEST
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| EGD | Ann: Weekly NTA Estimate | 24/04/18 | 0 | 28 | |||
|
|||||||
| EGD | Ann: Weekly NTA Estimate | 17/04/18 | 0 | 45 | |||
|
|||||||
| EGD | Ann: NTA and Fund Update | 10/04/18 | 0 | 59 | |||
|
|||||||
| EGD | Ann: Weekly NTA Estimate | 10/04/18 | 0 | 36 | |||
|
|||||||
| EGD | Ann: Weekly NTA Estimate | 03/04/18 | 0 | 73 | |||
|
|||||||
| EGD | Ann: Weekly NTA Estimate | 27/03/18 | 0 | 54 | |||
|
|||||||
| EGD | Ann: Weekly NTA Estimate | 20/03/18 | 0 | 52 | |||
|
|||||||
| EGD | Ann: Changes relating to buy-back - Appendix 3D | 15/03/18 | 0 | 50 | |||
|
|||||||
See All Discussions
ASX News